Track-and-trace will reshape Rx supply chain
Sweeping changes will begin to transform the pharmaceutical supply chain at the start of 2015, when the first provisions of the Drug Supply Chain Security Act take effect.
Latest
In brand marketing, relevance to consumer is critical
the retail buyer and the consumer/shopper. This objective picture of the two viewpoints should contribute to a product’s success at retail. In this column, we explore the ways promotion impacts buyer and shopper behavior.
Does ACA meet expectations for pharmacies?
The passage of the Patient Protection and Affordable Care Act in 2010 (ACA) promised fundamental changes in the American health care environment.
How big data will disrupt role of community pharmacy
Can retail pharmacies beat other players to patient intimacy? Many pharmacy retailers understand that big data can improve business operations, enabling intimate consumer engagement and thereby driving bigger baskets and more door turns, along with healthier customers and margins.
Merck acquires Cubist Pharmaceuticals
Merck & Co. said Monday it will acquire Cubist Pharmaceuticals Inc. for $8.4 billion. The transaction will include $1.1 billion in net debt (based on projected cash balances) and other considerations for a total transaction value of about $9.5 billion.
GSK decides not to sell older drugs
GlaxoSmithKline PLC (GSK) has reversed a plan to possibly sell some of its established drugs in order to focus on fast-growing medications.
First Quality Tissue expands production capacity
First Quality Tissue, a manufacturer of private-label and branded paper towels and tissue, is moving forward with several capacity expansion projects.
Galderma introduces Cetaphil Baby line
Galderma Laboratories’ Cetaphil skin care brand has made a foray in the baby product arena with the launch of Cetaphil Baby. Making its debut this week, the line includes five products: Cetaphil Baby Diaper Cream, Wash and Shampoo, Ultra Moisturizing Wash, Daily Lotion and Moisturizing Oil.
Avanir to be acquired by Otsuka for $3.5 billion
Avanir Pharmaceuticals Inc. has entered into an agreement to be acquired by Otsuka Pharmaceutical Co. Ltd. in a deal valued at $3.5 billion.
Actavis ships generic version of Intuniv
Actavis plc has released guanfacine hydrochloride tablets as part of a settlement agreement with Shire plc. Actavis said Monday that its product is a generic version of Shire’s Intuniv tablets, a medication for attention deficit hyperactivity disorder (ADHD).
Teva rolls out Exforge HCT generic in U.S.
Teva Pharmaceutical Industries Ltd. has launched amlodipine/valsartan/hydrochlorothiazide tablets, a hypertension medication, in the United States. Teva said Monday that its product is a generic equivalent of Exforge HCT tablets from Novartis.
PepsiCo announces global leadership appointments
PepsiCo make has made a pair of key executive appointments for its global operations. The food and beverage giant said Monday that Enderson Guimaraes, currently chief executive officer of PepsiCo Europe, has been named executive vice president of global categories and operations for PepsiCo.
Jelly Belly unveils Draft Beer Jelly Bean Bottles
Jelly Belly Candy Co. has introduced Draft Beer Jelly Bean Bottles in their own point-of-purchase display. Jelly Belly said Tuesday that the miniature plastic bottle is filled with 1.5 ounces of the Jelly Belly Draft Beer jelly beans, which made their debut this past spring.
Endo acquires rights to Natesto testosterone nasal gel
Endo International plc has purchased the rights to Natesto testosterone nasal gel from Trimel BioPharma SRL, a subsidiary of Trimel Pharmaceuticals Corp.
Bayer Consumer Care’s Heist to retire
David Heist, director of industry affairs and customer relations at Bayer Consumer Care, has announced his retirement. In an e-mail message to industry colleagues on Monday, Heist said he plans to retire from Bayer on May 1, 2015. He has served in his current position at Bayer for 20 years.
Perrigo releases Protopic authorized generic
Perrigo Co. plc has launched an authorized generic version of Protopic Ointment 0.1% and 0.03%. Perrigo said Monday that it has begun shipping its generic product to pharmacies. Protopic Ointment (tacrolimus), from Astellas U.S. LLC, is indicated for the treatment of moderate to severe eczema.